Hypernatremia Estimation and Treatment Strategies
Definition and clinical manifestations
Hypernatremia is defined as a serum sodium level > 145 mEq/L. Clinical symptoms range from lethargy, irritability, restlessness, muscle spasticity, hyperreflexia, seizures, coma, and death (in severe cases).
Estimation of free water deficit
Use the Adrogue-Madias equation for a rough estimate:
0.6 × wt (kg) × [serum sodium / 140 – 1]
For women, use 0.5 × wt (kg) instead of 0.6.
Note: This equation often underestimates total body water deficit.
Management of Hypernatremia
Acute Hypernatremia (≤ 48 hours): Rare
Goal: Decrease serum sodium by 1–2 mEq/L per hour, with a maximum of 10 mEq/L reduction in 24 hours.
Therapy: Administer 5% dextrose (D5W) IV at 3–6 mL/kg/h until serum sodium is 145 mEq/L.
- Monitor serum sodium q2–3hr.
- Once at 145 mEq/L, reduce D5W to 1 mL/kg/hr until serum sodium reaches 140 mEq/L.
Special cases (e.g., Central Diabetes Insipidus): Add desmopressin
- Intranasal: 5–10 mcg qhs
- Oral: 0.1–0.2 mg qhs
- Subcutaneous: 1 mcg q12hr (if intranasal/oral not feasible)
- IV: 2 mcg q12hr (if inadequate response to subcutaneous)
Chronic Hypernatremia (> 48 hours): Common
Goal: Reduce serum sodium by a maximum of 10 mEq/L per 24 hours.
Therapy: D5W IV 1.35 mL/hr × weight (kg).
- Concurrent hypovolemia: Use 0.225% NaCl at 1.8 mL/kg/hr.
- Concurrent hypovolemia + hypokalemia: Use 0.225% NaCl with KCl 40 mEq/L at 2.7 mL/kg/hr.
Monitor serum sodium q4–6hr until goal achieved, then q12–24hr.
Hypernatremia secondary to severe hyperglycemia (e.g., DKA, HHS): Use 0.45% NaCl at 6–12 mL/kg/hr.
Practical tips
- Hypernatremia requires careful and gradual correction to avoid complications like cerebral edema.
- Always adjust treatment based on the underlying cause (e.g., dehydration, central diabetes insipidus, hyperglycemia).
- Educate patients or caregivers on recognizing signs of worsening symptoms and the importance of timely follow-ups.
References
- Muhsin SA, Mount DB. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab. 2016;30(2):189-203.
- Rushlow D, Miller N, Stacey S. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia. American Family Physician. 2023;108(5):476-486.